Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid and Chondroitin Sulfate after TUR for Hunner Lesion in IC/BPS
NCT03463499Completed
- Sponsor
- Samsung Medical Center
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of hyaluronic acid and chondroitin sulfate in interstitial cystitis (IC) and bladder pain syndrome (BPS), sponsored by Samsung Medical Center. Primary endpoint: Change in recurrence rate at 24 months. Started Sep 2017; status: completed.
02
Drugs
hyaluronic acidchondroitin sulfate
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT03463499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463499.